For example, neutralization of IFN-γ or IL-12 [21], [22] or administration of IL-4 [23] during the early phase of disease has been shown to exert a protective effect on the evolution of arthritis, although these strategies were less effective or ineffective if administered during established disease. The gene discussed is IFNG; the disease is arthritic joint disease.